|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A double-blind, randomized,placebo-controlled dose-ranging study to eval- uate the efficacy of alosetron in the treatment of irritable bowelsyndrome 显示文摘 | Bardhan KD Bodemar G Geldof H | 2000 | Aliment Pharmacol Ther2000，14，1： | 1 |
| 2 | A double - blind, randomized, placebo- controlled dose -ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome 显示文摘 | Bardhan KD Bodemar G Geldof H | 2000 | Aliment Phannacol Ther2000，14，1： | 1 |
| 3 | A double blind, randomized, placebo controlled dose-ranging study to evaluate the efficacy of alosetron in the treat- ment of irritable bowel syndrome 显示文摘 | Bardhan K D Bodemar G Geldof H | 2002 | Aliment Phar macolTher2002，14，1： | 1 |
| 4 | Electrogastrographic study of gastric myoelectrical activity in patients with unexplained nausea and vomiting 显示文摘 | Geldof H Van der Schee E J van Blankenstein M | 1986 | Gut1986，27，7： | 1 |
| 5 | A double-blind,randomized,placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome显示文摘 | Bardhan KD Bodemar G Geldof H | 2002 | Aliment Pharmacol Ther2002，14，： | 1 |
| 6 | A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome 显示文摘 | Bardhan K D Bodemar G Geldof H | 2002 | Aliment Pharmacol Ther2002，14，1： | 1 |
| 7 | A double-blind,randomized,placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome显示文摘 | Bardhan KD Bodemar G Geldof H | 2002 | Aliment Pharmacol Ther2002，14，： | 1 |
| 8 | A double-blind,ran- domized, placebo-controlled dose-ranging study to e- valuate the efficacy of alosetron in the treatment of ir- ritable bowel syndrome 显示文摘 | Bardhan K D Bodemar G Geldof H | 2002 | Aliment Pharmacol T- her2002，14，1： | 1 |
| 9 | Electrogastrographic characteristics of interdigestive migrating complex in humans显示文摘 | van der Schee EJ Grashuis JL | 1986 | Am J Physiol1986，250，： | 1 |
| 10 | A double-blind,randomized,placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome显示文摘 | Bardhan KD Bodemar G Geldof H | 2000 | Aliment Pharmacol Timer2000，14，1： | 1 |
| 11 | A double - blind, randomized, placebo - controlled dose - ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome显示文摘 | Bardhan KD Bodemar G Geldof H | 2000 | Aliment Pharmacol Ther2000，14，： | 1 |
| 12 | A doubleblind,randomized,placebocontrolled doseranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome显示文摘 | Bardhan KD Bodemar G Geldof H | 2002 | Aliment Pharmacol Ther2002，14，： | 1 |
| 13 | Does Helicobaeter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole显示文摘 | de Boer W de Wit N Geldof H | 2006 | Scand J Gastroenteml2006，41，10： | 1 |
| 14 | A double - blind, randomized, placebo- controlled dose- ranging study to evalu- ate the efficacy of alosetron in the treatment of irritable bowel syndrome 显示文摘 | Bardhan KD Bodemar G Geldof H el al | 2000 | Aliment Pharmaeol Ther2000，14，1： | 1 |
| 15 | Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole?显示文摘 | De-Boer W De-Wit N Geldof H | 2006 | Scandin J Gastroenterol2006，41，10： | 1 |
| 16 | A double - blind, randomized, placebo - controlled dose - ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome显示文摘 | Bardhan KD Bodeman G Geldof H | 2000 | Aliment Pharmacol Ther2000，14，1： | 1 |
| 17 | Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole 显示文摘 | de Boer W de Wit N Geldof H | 2006 | Scand J Gastroenterol2006，41，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员